View Item 

Show simple item record

Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma

dc.contributor.authorArthur, Anna E.en_US
dc.contributor.authorPeterson, Karen E.en_US
dc.contributor.authorShen, Jinchengen_US
dc.contributor.authorDjuric, Zoraen_US
dc.contributor.authorTaylor, Jeremy M. G.en_US
dc.contributor.authorHebert, James R.en_US
dc.contributor.authorDuffy, Sonia A.en_US
dc.contributor.authorPeterson, Lisa A.en_US
dc.contributor.authorBellile, Emily L.en_US
dc.contributor.authorWhitfield, Joel R.en_US
dc.contributor.authorChepeha, Douglas B.en_US
dc.contributor.authorSchipper, Matthew J.en_US
dc.contributor.authorWolf, Gregory T.en_US
dc.contributor.authorRozek, Laura S.en_US
dc.date.accessioned2014-09-03T16:51:41Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-09-03T16:51:41Z
dc.date.issued2014-09-01en_US
dc.identifier.citationArthur, Anna E.; Peterson, Karen E.; Shen, Jincheng; Djuric, Zora; Taylor, Jeremy M. G.; Hebert, James R.; Duffy, Sonia A.; Peterson, Lisa A.; Bellile, Emily L.; Whitfield, Joel R.; Chepeha, Douglas B.; Schipper, Matthew J.; Wolf, Gregory T.; Rozek, Laura S. (2014). "Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma." Cancer 120(17): 2704-2712.en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108299
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherOxford University Pressen_US
dc.subject.otherDietary Patternsen_US
dc.subject.otherHead and Neck Canceren_US
dc.subject.otherCytokinesen_US
dc.subject.otherCarotenoidsen_US
dc.titleDiet and proinflammatory cytokine levels in head and neck squamous cell carcinomaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108299/1/cncr28778.pdf
dc.identifier.doi10.1002/cncr.28778en_US
dc.identifier.sourceCanceren_US
dc.identifier.citedreferenceAgresti A. Categorical Data Analysis. 3rd ed. New York: John Wiley & Sons, Inc.; 2012.en_US
dc.identifier.citedreferenceUpadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Association of interleukin‐6 (−174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol. 2008; 128: 199 ‐ 204.en_US
dc.identifier.citedreferenceArgiris A, Lee SC, Feinstein T, et al. Serum biomarkers as potential predictors of antitumor activity of cetuximab‐containing therapy for locally advanced head and neck cancer. Oral Oncol. 2011; 47: 961 ‐ 966.en_US
dc.identifier.citedreferencevan Bokhorst‐de van der S, von Blomberg‐van der Flier BM, Kuik DJ, et al. Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen‐DR expression and interleukin‐6/tumor necrosis factor‐alpha response of the monocyte. JPEN J Parenter Enteral Nutr. 2000; 24: 329 ‐ 336.en_US
dc.identifier.citedreferenceDuffy SA, Taylor JM, Terrell JE, et al. Interleukin‐6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008; 113: 750 ‐ 757.en_US
dc.identifier.citedreferenceAllen C, Duffy S, Teknos T, et al. Nuclear factor‐kappaB‐related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res. 2007; 13: 3182 ‐ 3190.en_US
dc.identifier.citedreferenceGalland L. Diet and inflammation. Nutr Clin Pract. 2010; 25: 634 ‐ 640.en_US
dc.identifier.citedreferenceHarvard School of Public Health. Harvard School of Public Health Nutrition Department's file download site. Available at: https://regepi.bwh.harvard.edu/health/FFQ/files. Accessed July 9, 2013.en_US
dc.identifier.citedreferenceWillett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985; 122: 51 ‐ 65.en_US
dc.identifier.citedreferenceRimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self‐administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992; 135: 1114 ‐ 1126; discussion 1127‐1136.en_US
dc.identifier.citedreferenceWillett W. Nutritional Epidemiology. 2nd ed. New York: Oxford University Press; 1998.en_US
dc.identifier.citedreferenceDjuric Z, Ren J, Blythe J, VanLoon G, Sen A. A Mediterranean dietary intervention in healthy American women changes plasma carotenoids and fatty acids in distinct clusters. Nutr Res. 2009; 29: 156 ‐ 163.en_US
dc.identifier.citedreferenceSaunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addiction. 1993; 88: 791 ‐ 804.en_US
dc.identifier.citedreferenceTang AL, Hauff SJ, Owen JH, et al. UM‐SCC‐104: a new human papillomavirus‐16‐positive cancer stem cell‐containing head and neck squamous cell carcinoma cell line. Head Neck. 2012; 34: 1480 ‐ 1491.en_US
dc.identifier.citedreferencePiccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital‐based cancer registry. JAMA. 2004; 291: 2441 ‐ 2447.en_US
dc.identifier.citedreferenceRosner BA. Percentage points for a generalized ESD many‐outlier procedure. Technometrics. 1983; 25: 165 ‐ 172.en_US
dc.identifier.citedreferenceHeidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation. 2008; 118: 230 ‐ 237.en_US
dc.identifier.citedreferenceHu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000; 72: 912 ‐ 921.en_US
dc.identifier.citedreferenceHu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002; 13: 3 ‐ 9.en_US
dc.identifier.citedreferenceArmitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955; 11: 375 ‐ 386.en_US
dc.identifier.citedreferenceFlegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999‐2010. JAMA. 2012; 307: 491 ‐ 497.en_US
dc.identifier.citedreferenceDuffy SA, Teknos T, Taylor JM, et al. Health behaviors predict higher interleukin‐6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013; 22: 374 ‐ 381.en_US
dc.identifier.citedreferenceAnderson AL, Harris TB, Tylavsky FA, et al. Dietary patterns, insulin sensitivity and inflammation in older adults. Eur J Clin Nutr. 2012; 66: 18 ‐ 24.en_US
dc.identifier.citedreferenceRichard C, Couture P, Desroches S, Lamarche B. Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome. Obesity (Silver Spring). 2013; 21: 51 ‐ 57.en_US
dc.identifier.citedreferenceD'Adamo CR, Miller RR, Shardell MD, et al. Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture. Clin Nutr. 2012; 31: 659 ‐ 665.en_US
dc.identifier.citedreferenceYeon JY, Suh YJ, Kim SW, et al. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition. 2011; 27: 912 ‐ 918.en_US
dc.identifier.citedreferenceAbranches MV, Mendes MC, Pena G, et al. Antioxidant vitamins and cytokines are altered in breast cancer. Eur J Cancer Prev. 2011; 20: 403 ‐ 410.en_US
dc.identifier.citedreferenceGupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM, Aggarwal BB. Role of nuclear factor kappaB‐mediated inflammatory pathways in cancer‐related symptoms and their regulation by nutritional agents. Exp Biol Med (Maywood). 2011; 236: 658 ‐ 671.en_US
dc.identifier.citedreferenceRimbach G, Valacchi G, Canali R, Virgili F. Macrophages stimulated with IFN‐gamma activate NF‐kappa B and induce MCP‐1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun. 2000; 3: 238 ‐ 242.en_US
dc.identifier.citedreferenceKarin M. Nuclear factor‐kappaB in cancer development and progression. Nature. 2006; 441: 431 ‐ 436.en_US
dc.identifier.citedreferenceGupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF‐kappaB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta. 2010; 1799: 775 ‐ 787.en_US
dc.identifier.citedreferenceGonzalez R, Ballester I, Lopez‐Posadas R, et al. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr. 2011; 51: 331 ‐ 362.en_US
dc.identifier.citedreferenceDuffy SA, Ronis DL, McLean S, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol. 2009; 27: 1969 ‐ 1975.en_US
dc.identifier.citedreferenceSandoval M, Font R, Manos M, et al. The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain. Int J Oral Maxillofac Surg. 2009; 38: 31 ‐ 39.en_US
dc.identifier.citedreferenceMayne ST, Cartmel B, Lin H, Zheng T, Goodwin WJ Jr. Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx or larynx cancers. J Am Coll Nutr. 2004; 23: 34 ‐ 42.en_US
dc.identifier.citedreferenceSakhi AK, Bohn SK, Smeland S, et al. Postradiotherapy plasma lutein, alpha‐carotene, and beta‐carotene are positively associated with survival in patients with head and neck squamous cell carcinoma. Nutr Cancer. 2010; 62: 322 ‐ 328.en_US
dc.identifier.citedreferenceArthur AE, Peterson KE, Rozek LS, et al. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis. Am J Clin Nutr. 2013; 97: 360 ‐ 368.en_US
dc.identifier.citedreferenceCandido J, Hagemann T. Cancer‐related inflammation. J Clin Immunol. 2013; 33 (suppl 1 ): S79 ‐ S84.en_US
dc.identifier.citedreferenceBrozek W, Bises G, Girsch T, Cross HS, Kaiser HE, Peterlik M. Differentiation‐dependent expression and mitogenic action of interleukin‐6 in human colon carcinoma cells: relevance for tumour progression. Eur J Cancer. 2005; 41: 2347 ‐ 2354.en_US
dc.identifier.citedreferenceLauta VM. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer. 2003; 97: 2440 ‐ 2452.en_US
dc.identifier.citedreferencePelliniemi TT, Irjala K, Mattila K, et al. Immunoreactive interleukin‐6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group. Blood. 1995; 85: 765 ‐ 771.en_US
dc.identifier.citedreferenceAndrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Preoperative plasma levels of interleukin‐6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol. 2002; 167: 1475 ‐ 1481.en_US
dc.identifier.citedreferenceChung YC, Chang YF. Serum interleukin‐6 levels reflect the disease status of colorectal cancer. J Surg Oncol. 2003; 83: 222 ‐ 226.en_US
dc.identifier.citedreferenceRiedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K. Serum levels of interleukin‐6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res. 2005; 25: 2761 ‐ 2765.en_US
dc.identifier.citedreferenceChen Z, Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999; 5: 1369 ‐ 1379.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr28778.pdf
Size:
119.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.